Poster GI101, A novel CD80-IgG4-IL2 variant bispecific protein, inhibits tumor growth and induces anti-tumor immune response in multiple preclinical models
페이지 정보
작성자 DAAN
조회 291회 작성일 24-02-16 16:15
조회 291회 작성일 24-02-16 16:15
본문
| Journal | AACR |
|---|---|
| Name | 표경호, 신춘봉, 김재환 |
| Year | 2020 |
첨부파일
-
2020-AACR-Poster-GI-innovation.pdf (1.9M)
0회 다운로드 | DATE : 2024-02-16 16:15:49
- 이전글Reinforcement of tumor antigen presentation and T cell activation with STING pathway on metastatic colon cancer; application for whole cancer cell vaccination 24.02.16
- 다음글Enhanced antitumor and immue-stimulatory effects of a novel AXL inhibitor, SKI-G-801, and anti-PD-1 combination in multiple solid tumors. 24.02.16